Abstract:Background: Treatment of heart failure post myocardial infarction (post-MI HF) with mesenchymal stem/stromal cells (MSCs) holds great promise. Nevertheless, 2-dimensional (2D) GMP-grade MSCs from different labs and donor sources have different therapeutic efficacy and still in a low yield. Therefore, it is crucial to increase the production and find novel ways to assess the therapeutic efficacy of MSCs. Materials and methods: hUC-MSCs were cultured in 3-dimensional (3D) expansion system for obtaining enough cells for clinical use, named as 3D MSCs. A post-MI HF mouse model was employed to conduct in vivo and in vitro experiments. Single-cell and bulk RNA-seq analyses were performed on 3D MSCs. A total of 125 combination algorithms were leveraged to screen for core ligand genes. Shinyapp and shinycell workflows were used for deploying web-server. Result: 3D GMP-grade MSCs can significantly and stably reduce the extent of post-MI HF. To understand the stable potential cardioprotective mechanism, scRNA-seq revealed the heterogeneity and division-of-labor mode of 3D MSCs at the cellular level. Specifically, scissor phenotypic analysis identified a reported wound-healing CD142 + MSCs subpopulation that is also associated with cardiac protection ability and CD142 - MSCs that is in proliferative state, contributing to the cardioprotective function and self-renewal, respectively. Differential expression analysis was conducted on CD142 + MSCs and CD142 - MSCs and the differentially expressed ligand-related model was achieved by employing 125 combination algorithms. The present study developed a machine learning predictive model based on 13 ligands. Further analysis using CellChat demonstrated that CD142 + MSCs have a stronger secretion capacity compared to CD142 - MSCs and Flow cytometry sorting of the CD142 + MSCs and qRT-PCR validation confirmed the significant upregulation of these 13 ligand factors in CD142 + MSCs. Conclusion: Clinical GMP-grade 3D MSCs could serve as a stable cardioprotective cell product. Using scissor analysis on scRNA-seq data, we have clarified the potential functional and proliferative subpopulation, which cooperatively contributed to self-renewal and functional maintenance for 3D MSCs, named as "division of labor" mode of MSCs. Moreover, a ligand model was robustly developed for predicting the secretory efficacy of MSCs. A user-friendly web-server and a predictive model were constructed and available (https://wangxc.shinyapps.io/3D_MSCs/).

Preliminary Research on a Mesenchymal Stem Cell-model for Screening Traditional Chinese Medicines

Immunomodulative Effects of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells in Vivo and in Vitro

Screening and Cluster of Differentially Expressed Gene of Mscs Induced by Shuanglong Prescription Components

The preliminarily investigation of therapeutic effects of mesenchymai stem cells on rat fulminant hepatic failure

Protein Expression of Differentiation of Bone Marrow Mesenchymal Stem Cells Induced by Shuanglong Formula

e0205 MicroRNA regulation of cardiomyocyte lineages from bone marrowderived mesenchymal stem cells

Comparative proteomics research on rat MSCs differentiation induced by Shuanglong Formula.

A Cocktail Method for Promoting Cardiomyocyte Differentiation from Bone Marrow-Derived Mesenchymal Stem Cells

An Experimental Study on Inducing Bone Marrow Mesenchymal Stem Cell to Differentiate into Cardiomyogenic Cells in Cardiomyocyte Cultered Microenviroment in Vitro

Serum Metabolomics Reveals the Effectiveness of Human Placental Mesenchymal Stem Cell Therapy for Crohn's Disease

Identification and Differentiation of Magnetically Labeled Mesenchymal Stem Cells in Vivo in Swines with Myocardial Infarction.

The Application of Resveratrol to Mesenchymal Stromal Cell-Based Regenerative Medicine.

Differentiation of Bone Marrow Mesenchymal Stem Cells Induced by Myo-Cardial Medium under Hypoxic Conditions

An Improved Protocol for Isolating and increasing the Multiple Differentiation Potentials of Mesenchymal Stem Cells from Human Bone Marrow

Effective Components Screening and Anti-Myocardial Infarction Mechanism Study of the Chinese Medicine NSLF6 Based on "system to System" Mode

A division-of-labor mode contributes to the cardioprotective potential of mesenchymal stem/stromal cells in heart failure post myocardial infarction

Label-Free Imaging of Mesenchymal Stem Cell Spheroid Differentiation with Flexible-Probe SECM and a Microfluidic Device

Effect assessment of a type of xeno-free and serum-free human adipose-derived mesenchymal stem cells culture medium by proliferation and differentiation capacities

Evaluating Differentiation Status of Mesenchymal Stem Cells by Label-Free Microscopy System and Machine Learning.

Improving the immunomodulatory function of mesenchymal stem cells by defined chemical approach

Metabonomic Study of Chinese Medicine Shuanglong Formula As an Effective Treatment for Myocardial Infarction in Rats